Feb 13 (Reuters) - CSL Ltd (CSL) :
- FY24 NPATA ANTICIPATED TO BE IN RANGE OF APPROXIMATELY $2.9 BILLION TO $3.0 BILLION AT CC
- IN A STRONG POSITION TO DELIVER ANNUALISED DOUBLE-DIGIT EARNINGS GROWTH OVER MEDIUM TERM
- FOR CSL VIFOR, WELL PREPARED FOR THE TRANSITIONING IRON MARKET
- DUE TO SEASONALITY OF CSL SEQIRUS BUSINESS, ANTICIPATE IT TO POST A LOSS IN 2H OF FY24
- STRONG GROWTH IN IMMUNOGLOBULINS FRANCHISE EXPECTED TO CONTINUE AS PATIENT DEMAND REMAINS STRONG
- PLASMA INITIATIVES IMPLEMENTED ARE STARTING TO DRIVE GROSS MARGIN RECOVERY
News: CSL CSL Says Expect FY24 NPATA Of About $2.9 To $3.0 Bln At Constant Currency
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$198.37 |
Change
0.030(0.02%) |
Mkt cap ! $96.23B | |||
| Open | High | Low | Value | Volume |
| $200.98 | $203.69 | $198.37 | $647.4M | 3.086M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 428 | $198.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $198.40 | 360 | 2 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| CSL (ASX) Chart |